Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-18
2011-12-06
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C435S184000, C514S248000, C514S184000, C514S243000, C544S118000, C544S236000
Reexamination Certificate
active
08071581
ABSTRACT:
The present disclosure relates to triazolopyridazine protein kinase modulators of Formula (I), methods of using these compounds to treat diseases mediated by kinase activity.
REFERENCES:
patent: WO 02/083139 (2002-10-01), None
patent: WO 02/083675 (2002-10-01), None
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, p. 18).
bian et al “Azabenzenes (Azines)—The nitrogen derivatives of benzene with one to six N atoms: stability, homodesmotic stabilization energy, electron distribution, and magnetic ring current; a computational study”, Can. J. Chem. vol. 82, pp. 50-69, 2004.
Target et al “Synthetic inhibitors of interleukin-6 II: 3,5-diaryl pyridines and meta-terphenyls”, Biorganic & Medicinal Chemistry Letters, vol. 5, No. 18, pp. 2143-2146, 1995.
Schafer et al. Drug Discovery Today 2008, 13 (21/22), 913-916.
Horig et al. Journal of Translational Medicine 2004, 2(44).
Sawyer et al “Synthesis and activity of New Aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain”. Journal of Medicinal Chemistry, vol. 46, No. 19, Sep. 11, 2003.
Wolff Burgers Medicinal Chemistry and Drug Discovery, Fifth Edition, vol. I: Principles and Practice, Wiley-Interscience 1995, pp. 974-977.
Bounaud Pierre-Yves
Jefferson Elizabeth Anne
Lee Patrick S.
Smith Christopher Ronald
Torres Eduardo
Cornet Jean
Fetterolf Brandon
Ginah Francis O.
Sales James J.
SGX Pharmaceuticals Inc.
LandOfFree
Triazolopyridazine protein kinase modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyridazine protein kinase modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyridazine protein kinase modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4313980